Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-08 Purchase | 2025-08-12 6:00 pm | HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim 10% Owner | 2,387,225 | $1.5 | $3,580,838 | 64,195,338 (Indirect) | View |
| 2025-08-08 Purchase | 2025-08-12 5:02 pm | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 1,766,546 | $1.5 | $2,649,819 | 8,893,079 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-06 Exercise | 2026-06-08 10:27 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 12,500 | $0 | 234,111 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 1:01 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Hensley Mark Earl Chief Operating Officer | 125,000 | $0 | 511,770 (Direct) | View |
| 2026-04-30 Exercise | 2026-05-04 12:49 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Hensley Mark Earl Chief Operating Officer | 11,770 | $0 | 188,315 (Direct) | View |
| 2026-04-30 Exercise | 2026-05-04 12:35 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 23,464 | $0 | 514,294 (Direct) | View |
| 2026-04-30 Exercise | 2026-05-04 11:56 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 25,229 | $0 | 583,793 (Direct) | View |
| 2026-04-30 Exercise | 2026-05-04 11:30 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 84,810 | $0 | 1,890,876 (Direct) | View |
| 2026-04-19 Exercise | 2026-04-21 11:15 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,874 | $0 | 212,767 (Direct) | View |
| 2026-04-19 Exercise | 2026-04-21 09:41 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,797 | $0 | 758,810 (Direct) | View |
| 2026-04-19 Exercise | 2026-04-21 09:13 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,874 | $0 | 242,996 (Direct) | View |
| 2026-04-03 Exercise | 2026-04-06 7:06 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 62,500 | $0 | 710,755 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 1,600,673 | $0 | 1,600,673 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Christian Waage Director | 53,960 | $0 | 53,960 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director | 53,960 | $0 | 53,960 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 433,123 | $0 | 433,123 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director | 53,960 | $0 | 53,960 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Cusack Thomas Director | 53,960 | $0 | 53,960 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 376,629 | $0 | 376,629 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director | 53,960 | $0 | 53,960 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 10:00 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Hensley Mark Earl Chief Operating Officer | 376,629 | $0 | 376,629 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 09:15 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 53,960 | $0 | 8,877,027 (Direct) | View |
| 2026-01-31 Exercise | 2026-02-03 08:30 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 11,695 | $0 | 335,688 (Direct) | View |
| 2026-01-31 Exercise | 2026-02-03 08:30 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 11,695 | $0 | 322,105 (Direct) | View |
| 2026-01-31 Exercise | 2026-02-03 08:30 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 34,789 | $0 | 989,174 (Direct) | View |
| 2026-01-19 Exercise | 2026-01-20 3:00 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,875 | $0 | 201,072 (Direct) | View |
| 2026-01-19 Exercise | 2026-01-20 2:49 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,875 | $0 | 214,655 (Direct) | View |
| 2026-01-19 Exercise | 2026-01-20 2:39 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,797 | $0 | 647,296 (Direct) | View |
| 2025-11-08 Option Award | 2025-11-12 09:20 am | N/A 2035-11-08 | HERON THERAPEUTICS INC. | HRTX | Cusack Thomas Director | 227,272 | $1.1 | 265,151 (Direct) | View |
| 2025-11-08 Option Award | 2025-11-12 09:20 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Cusack Thomas Director | 37,879 | $0 | 265,151 (Direct) | View |
| 2025-10-31 Exercise | 2025-11-04 12:35 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 11,694 | $0 | 318,230 (Direct) | View |
| 2025-10-31 Exercise | 2025-11-04 12:33 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 11,694 | $0 | 331,813 (Direct) | View |
| 2025-10-31 Exercise | 2025-11-04 12:31 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 34,789 | $0 | 975,377 (Direct) | View |
| 2025-10-19 Exercise | 2025-10-21 11:56 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,874 | $0 | 189,378 (Direct) | View |
| 2025-10-19 Exercise | 2025-10-21 11:42 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,874 | $0 | 202,961 (Direct) | View |
| 2025-10-19 Exercise | 2025-10-21 11:23 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,797 | $0 | 612,507 (Direct) | View |
| 2025-10-15 Conversion | 2025-10-17 6:00 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim 10% Owner | 1,040,710 | $0 | 65,046,828 (Indirect) | View |
| 2025-07-31 Exercise | 2025-08-04 5:29 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 11,695 | $0 | 314,356 (Direct) | View |
| 2025-07-31 Exercise | 2025-08-04 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 11,695 | $0 | 327,939 (Direct) | View |
| 2025-07-31 Exercise | 2025-08-04 5:21 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 34,789 | $0 | 961,580 (Direct) | View |